Now, women experiencing morning sickness can benefit from Diclegis drug

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness. Many turn to conservative management such as diet and lifestyle changes, however if this does not provide relief, women should speak with their healthcare professional about prescription treatment options.

Diclegis is the only FDA-approved prescription NVP treatment for women who do not respond to conservative management. Approved in April 2013, the FDA granted Diclegis Pregnancy Category A status, its highest rating.

Duchesnay USA, the maker of Diclegis, is dedicated to providing pregnant women with safe and effective pharmacological treatments.

Source:

Duchesnay USA

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Researchers identify two distinct phenotypes of COVID-19-associated ARDS